Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury

NCT01597518 is registered in ClinicalTrials.gov with AOSpine North America Research Network as lead sponsor.

NCT NCT01597518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury
Lead sponsor
AOSpine North America Research Network
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2013
Completion date
October 8, 2020
Enrollment
193 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury